Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7593-7609
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7593
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7593
Table 1 The addresses of databases
| Database | Address |
| TCMSP | http://www.tcmspw.com/tcmsp.php |
| TCMID | http://www.megabionet.org/tcmid/ |
| UniProt | https://www.uniprot.org/ |
| PubChem | https://pubchem.ncbi.nlmnih.gov |
| SwissTargetPrediction | http://www.swisstargetprediction.ch/ |
| Genecards | https://www.genecards.org |
| TTD | http://bidd.nus.edu.sg/group/ttd/ttd.asp |
| OMIM | https://omim.org/ |
| DisGeNET | https://www.disgenet.org/home/ |
| Venn platform | https://bioinfogp.cnb.csic.es/tools/venny/index.html |
| String | https://string-db.org/ |
| DAVID 6.8 | http://david.ncifcrf.gov |
| Omicstudio | https://www.omicstudio.cn/tool |
| PDB | https://www.rcsb.org |
Table 2 Active ingredients and absorption, distribution, metabolism and excretion parameters of Liu-Wei-Bu-Qi capsule
| No. | Compound | PubChem CID | ADMET-SOLUBLITY-level | ADMET-absorption-level | Herb |
| SSS1 | Arachidonate | 5312542 | 2 | 1 | SSS |
| SSS2 | Celabenzine | 442847 | 3 | 0 | SSS |
| SSS3 | Deoxyharringtonine | 285342 | 2 | 0 | SSS |
| SSS4 | Dianthramine | 441562 | 3 | 1 | SSS |
| SSS5 | Frutinone A | 441965 | 2 | 0 | SSS |
| SSS6 | Ginsenoside rh2 | 119307 | 2 | 2 | SSS |
| SSS7 | Girinimbine | 96943 | 1 | 0 | SSS |
| SSS8 | Gomisin B | 6438572 | 1 | 1 | SSS |
| SSS9 | Kaempferol | 5280863 | 3 | 0 | SSS |
| SSS10 | Maackiain | 91510 | 2 | 0 | SSS |
| SSS11 | Malkangunin | 90473155 | 3 | 0 | SSS |
| SSS12 | Panaxadiol | 73498 | 1 | 0 | SSS |
| SSS13 | Protopine | 4970 | 2 | 0 | SSS |
| SSS14 | Suchilactone | 132350840 | 2 | 0 | SSS |
| ZHQ1 | 3,9,10-Trimethoxypterocarpan | 15689655 | 2 | 0 | ZHQ |
| ZHQ2 | 7-O-methylisomucronulatol | 15689652 | 2 | 0 | ZHQ |
| ZHQ3 | Antibiotic FA 2097 | 102059896 | 3 | 0 | ZHQ |
| ZHQ4 | Betulinic acid | 64971 | 1 | 2 | ZHQ |
| ZHQ5 | Calycosin | 5280448 | 3 | 0 | ZHQ |
| ZHQ6 | Formononetin | 5280378 | 3 | 0 | ZHQ |
| ZHQ7 | Hederagenin | 73299 | 1 | 1 | ZHQ |
| ZHQ8 | Isoflavanone | 160767 | 2 | 0 | ZHQ |
| ZHQ9 | Isorhamnetin | 5281654 | 3 | 0 | ZHQ |
| ZHQ10 | Kaempferol | 5280863 | 3 | 0 | ZHQ |
| ZHQ11 | Kumatakenin | 5318869 | 3 | 0 | ZHQ |
| ZHQ12 | Quercetin | 5280343 | 3 | 1 | ZHQ |
| YZR1 | (+)-delta-cadinene | 441005 | 2 | 1 | YZR |
| YZR2 | Caryophyllene oxide | 1742210 | 2 | 0 | YZR |
| YZR3 | Chrysin | 5281607 | 3 | 0 | YZR |
| YZR4 | Daucosterol | 5742590 | 2 | 2 | YZR |
| YZR5 | Globulol | 12304985 | 2 | 0 | YZR |
| YZR6 | Isocyperol | 14076604 | 2 | 0 | YZR |
| YZR7 | Linolenic acid | 5280934 | 2 | 1 | YZR |
| YZR8 | Nootkatol | 182645 | 2 | 0 | YZR |
| YZR9 | O-cymene | 10703 | 3 | 0 | YZR |
| YZR10 | Oleic acid | 445639 | 2 | 2 | YZR |
| YZR11 | Protocatechuic acid | 72 | 4 | 0 | YZR |
| YZR12 | Valencene | 9855795 | 2 | 1 | YZR |
| YZ1 | 4',5,7-trihydroxy-6,8-dimethyl-homoisoflavanone | 46886731 | 2 | 0 | YZ |
| YZ2 | 4',5,7-trihydroxy-6-methyl-8-methoxy-homoisoflavanone | 46886730 | 3 | 0 | YZ |
| YZ3 | N-cis-Feruloyltyramine | 6440659 | 3 | 0 | YZ |
| YZ4 | P-Coumaroyltyramine | 5372945 | 3 | 0 | YZ |
| RG1 | (-)-alpha-cedrene | 6431015 | 2 | 0 | RG |
| RG2 | (-)-Caryophyllene oxide | 1742210 | 2 | 0 | RG |
| RG3 | ()-Sativene | 11275742 | 2 | 0 | RG |
| RG4 | (+)-Aromadendrene | 11095734 | 2 | 0 | RG |
| RG5 | Beta-Cubebene | 93081 | 2 | 0 | RG |
| RG6 | Copaene | 19725 | 2 | 0 | RG |
| RG7 | Diisobutyl phthalate | 6782 | 2 | 0 | RG |
| RG8 | Junipene | 1796220 | 2 | 0 | RG |
| RG9 | Ledene | 10910653 | 2 | 0 | RG |
| RG10 | Linoleic acid | 5280450 | 2 | 1 | RG |
| RG11 | Oleic acid | 445639 | 2 | 2 | RG |
| CP1 | 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one | 676152 | 3 | 0 | CP |
| CP2 | Citromitin | 12303287 | 2 | 0 | CP |
| CP3 | Naringetol | 932 | 3 | 0 | CP |
| CP4 | Nobiletin | 72344 | 2 | 0 | CP |
Table 3 Analysis of topological parameters of key targets
| Name | Closeness | Betweenness | Degree |
| TP53 | 0.839506 | 0.095155 | 56 |
| EGFR | 0.790698 | 0.051782 | 51 |
| ALB | 0.781609 | 0.077526 | 50 |
| ESR1 | 0.747253 | 0.054759 | 47 |
| HSP90AA1 | 0.764045 | 0.074274 | 47 |
| SRC | 0.73913 | 0.035499 | 45 |
| HIF1A | 0.731183 | 0.023561 | 44 |
| MAPK3 | 0.723404 | 0.033332 | 43 |
| TNF | 0.708333 | 0.027768 | 41 |
| MAPK1 | 0.660194 | 0.018393 | 34 |
| PTGS2 | 0.660194 | 0.013252 | 34 |
| SMAD3 | 0.635514 | 0.007272 | 30 |
| AR | 0.618182 | 0.005023 | 29 |
| STAT1 | 0.623853 | 0.00514 | 29 |
| MMP9 | 0.62963 | 0.006427 | 29 |
| IGF1R | 0.623853 | 0.00413 | 28 |
Table 4 Kyoto Encyclopedia of Genes and Genomes pathway enrichment information
| Pathway | Count | P value |
| Estrogen signaling pathway | 11 | 1.09E-08 |
| Thyroid hormone signaling pathway | 10 | 5.77E-08 |
| VEGF signaling pathway | 7 | 5.6E-07 |
| Toll-like receptor signaling pathway | 8 | 1.92E-06 |
| Prolactin signaling pathway | 7 | 2.44E-06 |
| FoxO signaling pathway | 8 | 1.27E-05 |
| PI3K-Akt signaling pathway | 13 | 3.76E-05 |
| HIF-1 signaling pathway | 7 | 4.45E-05 |
| Sphingolipid signaling pathway | 7 | 5.48E-05 |
| Neurotrophin signaling pathway | 7 | 5.77E-05 |
Table 5 Molecular docking for key targets and their related compounds
| Targets | PDB ID | Compounds | Binding energy (kcal/mol) |
| TP53 | 4MZR | protocatechuic acid | -42.1348 |
| ALB | 4BKE | Dianthramine | -49.0138 |
| ESR1 | 4ZNH | quercetin | -37.218 |
| kaempferol | -37.1051 | ||
| HSP90AA1 | 3WQ9 | quercetin | -40.1408 |
| kaempferol | -38.241 | ||
| SRC | 1Y57 | quercetin | -37.7868 |
| HIF1A | 1L8C | quercetin | -38.3202 |
| kaempferol | -49.377 | ||
| MAPK3 | 2ZOQ | quercetin | -61.2015 |
| TNF | 2E7A | quercetin | -50.4514 |
| MAPK1 | 1TVO | formononetin | -48.1226 |
- Citation: Yang Q, Li LY. Network pharmacological and molecular docking study of the effect of Liu-Wei-Bu-Qi capsule on lung cancer. World J Clin Cases 2023; 11(31): 7593-7609
- URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7593.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7593
